“Giant cell arteritis manifesting as retinal arterial occlusion and paracentral acute middle maculopathy in a patient on pembrolizumab for metastatic uveal melanoma”

PURPOSE: To report the association of pembrolizumab, an immune checkpoint inhibitor (ICI), with giant cell arteritis (GCA) presenting as paracentral acute middle maculopathy (PAMM) secondary to retinal arterial occlusion. OBSERVATIONS: 86-year old male with history of treated choroidal melanoma now...

Descripción completa

Detalles Bibliográficos
Autores principales: Narala, Ramsudha, Reddy, Sunil A., Mruthyunjaya, Prithvi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472807/
https://www.ncbi.nlm.nih.gov/pubmed/32913923
http://dx.doi.org/10.1016/j.ajoc.2020.100891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472807/
https://www.ncbi.nlm.nih.gov/pubmed/32913923
http://dx.doi.org/10.1016/j.ajoc.2020.100891

Ejemplares similares